- Exchange: Stockholm
- Sector: Technology
- Industry: Software
- Sub-Industry: Medical Information Sys
Price not available for AEROBTAB:SS
Snapshot for Aerocrine AB (AEROBTAB)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 10.4500 | 52wk Range: | - | 1-Yr Rtn: | - |
Key Statistics for AEROBTAB
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. OMX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M SEK) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AEROBTAB
Company Profile & Key Executives for AEROBTAB
Aerocrine AB researches, developes, and sells systems and products for measuring airway inflammation. The Company has developed a method for diagnosing inflammatory diseases, especially asthma, but also in the gastrointestinal tract and the urogenital organs. Aerocrine's software system is sold through distributors worldwide.
| Rolf A ClassonChairman | Scott MyersPresident/CEO |
| Michael ColerusChief Financial Officer | Kathleen Rickard "Kathy"Chief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AEROBTAB News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page